Neurochemists study the chemical foundations of brain activity, focusing on the roles of neurotransmitters, receptors, and signaling pathways that influence neural function. Their research helps explain how imbalances in brain chemistry contribute to disorders like depression, schizophrenia, and neurodegenerative diseases such as Parkinson's. Neurochemists investigate the synthesis, release, and recycling of neurotransmitters like dopamine, serotonin, and glutamate, which are key targets for many neurological and psychiatric treatments. Using advanced techniques such as chromatography, mass spectrometry, and molecular assays, they analyze the chemical composition of brain tissue and cerebrospinal fluid, providing critical insights into brain function and dysfunction.
Additionally, neurochemists explore the impact of neuropeptides, oxidative stress, and lipid signaling in processes such as neuroinflammation and neurodegeneration. By collaborating with neuropharmacologists and neurobiologists, they play a pivotal role in designing more effective, targeted therapies with fewer side effects. Their work also includes understanding how lifestyle factors such as diet, environmental exposure, and aging influence brain chemistry, contributing to the field of precision medicine. With this approach, neurochemists are advancing personalized treatment strategies that track and treat neurological conditions with greater accuracy.
Title : Perception and individuality
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : ACE-dependent Alzheimer’s Disease (AD)
Sergei M Danilov, University of Illinois, United States
Title : Essential roles, mechanisms and consequences of vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : Neuroimaging by evaluation nerverenovate and neuroplasticity of acupuncture in children with cerebral palsy
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : The foundation and architecture of Personalized & Precision Medicine (PPM) in clinical neurology: Towards curative and neurodegenerative disease-modifying treatment for multiple sclerosis
Sergey Suchkov, R&D Director of the National Center for Human Photosynthesis, Mexico
Title : Who cares …… for the carers
Jaqueline Tuppen, COGS Club, United Kingdom